Exclusive

Publication

Byline

Singapore Clinical Trial: A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab Adizutecan in Combination with Osimertinib as First-Line Treatment in Patients with Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Singapore, April 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab A... Read More


Singapore Clinical Trial: A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Retained Gastric Contents Using Gastric Ultrasound in Participants with Type 2 Diabetes Mellitus and Participants with Overweight or Obesity without Type 2 Diabetes Mellitus.

Singapore, April 1 -- The Health Sciences Authority received information related to the study titled 'A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Ret... Read More


Singapore Clinical Trial: A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Retained Gastric Contents Using Gastric Ultrasound in Participants with Type 2 Diabetes Mellitus and Participants with Overweight or Obesity without Type 2 Diabetes Mellitus.

Singapore, April 1 -- The Health Sciences Authority received information related to the study titled 'A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Ret... Read More


Singapore Clinical Trial: A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy in Participants With 1L Locally Advanced Unresectable/Metastatic Esophageal Cancer: KEYMAKER-U06 Substudy 06E

Singapore, April 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination Wi... Read More


Singapore Clinical Trial: EASi-PROTKT™ - A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral vicadrostat (BI 690517) and empagliflozin compared with placebo and empagliflozin in participants with type 2 diabetes, hypertension and established cardiovascular disease

Singapore, April 1 -- The Health Sciences Authority received information related to the study titled 'EASi-PROTKT™ - A Phase III double-blind, randomised, parallel-group superiority trial to evaluate ... Read More


Cuttack tragedy: Woman dies after third-floor fall in Badambadi, inquiry on

Bhubaneswar, April 1 -- A young womandied under suspicious circumstances after falling from the third floor in Cuttack's Badambadi area late on Tuesday night. The incident has raised concerns, with in... Read More


RBI extends export credit relief till June 30 amid West Asia crisis

Mumbai, April 1 -- The Reserve Bank of India on Tuesday extended the enhanced export credit period of up to 450 days for pre-shipment and post-shipment finance for disbursals made till June 30, citing... Read More


Gmail ID change : ఇక మీ పాత జీమెయిల్ ఐడీని మార్చుకోవచ్చు- డేటా పోకుండా !ఇలా చేయండి..

భారతదేశం, ఏప్రిల్ 1 -- టెక్ దిగ్గజం గూగుల్ తాజాగా ఒక సంచలన ప్రకటన చేసింది. గత దశాబ్ద కాలంగా యూజర్లు కోరుతున్న ఒక అప్‌డేట్‌ను ఎట్టకేలకు అందుబాటులోకి తీసుకువచ్చింది. దీని ప్రకారం.. యూజర్లు తమ ప్రధాన గూగ... Read More


U.S. Manufacturing Index Unexpectedly Indicates Slightly Faster Growth In March

India, April 1 -- A report released by the Institute for Supply Management on Wednesday unexpectedly showed slightly faster growth in U.S. manufacturing activity in the month of March. The ISM said i... Read More


Czech Manufacturing Growth Strongest Since April 2022

India, April 1 -- Czech factory activity logged renewed expansion in March and at the quickest pace in nearly four years amid favorable demand conditions, survey data from S&P Global showed on Wednesd... Read More